HCV-related fibrosis progression following liver transplantation: Increase in recent years

Journal of Hepatology

Volumn 32, Issue 4, 2000, Pages 673-684

  Berenguer, Marina ^a   Ferrell, Linda ^a   Watson, Jessica ^a   Prieto, Martin ^a   Kim, Michael ^a   Rayón, Miguel ^a   Córdoba, Juan ^a   Herola, Antonio ^a   Ascher, Nancy ^b   Mir, José ^a   Berenguer, Joaquín ^a   Wright, Teresa L ^a,c  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b Vet Admin Med Ctr/Univ C   (Spain)

^c SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Genotype; Immunosuppression; Natural history; Race; Viral quantitation

Indexed keywords

METHYLPREDNISOLONE;

ADULT; AGED; ARTICLE; FEMALE; GENOTYPE; HEPATITIS C VIRUS; HUMAN; IMMUNOCOMPETENCE; LIVER BIOPSY; LIVER FIBROSIS; LIVER INJURY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RACE DIFFERENCE; SCORING SYSTEM;

EID: 0034070192     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80231-7     Document Type: Article

References (32)

1. Annual Report of the U.S. Scientific Registry for Transplant Recipients and the Organ Procurement and Transplantation Network-Transplant Data: 1988-1994 Richmond VA, United Network for Organ Sharing, and the Division of Organ Transplantation, Bureau of Health Resources Dev.
2. Prieto M, Berenguer M, Rimola A, Loinaz C, Barrios C, Clemente G, et al. Liver transplantation in hepatitis C: a Spanish multicenter experience. Eur J Gastroenterol Hepatol. 10:1998;771-776.
3. Wright T, Donegan E, Hsu H, Ferrell L, Lake JR, Kim M, et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology. 103:1992;317-322.
4. Ferrell L, Wright T, Roberts J, Ascher N, Lake J. Hepatitis C viral infection in liver transplant recipients. Hepatology. 16:1992;865-876.
5. Feray C, Gigou M, Samuel D, Paradis V, Wilber J, David MF, et al. The course of hepatitis C virus infection after liver transplantation. Hepatology. 20:1994;1137-1143.
6. Gane E, Portmann B, Naoumov N, Smith HM, Underhill JA, Donaldson PT, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med. 334:1996;815-820.
7. Shiffman M, Contos M, Luketic V, Sanyal AJ, Purdum PP3rd, Mills AS, et al. Biochemical and histological evaluation of recurrent hepatitis C following orthotopic liver transplantation. Transplantation. 57:1994;526-532.
8. Prieto M, Berenguer M, Rayón M, Córdoba J, Argüello L, Carrasco D, et al. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes. Hepatology. 29:1999;250-256.
9. Boker KHW, Dalley G, Bahr MJ, Maschek H, Tillmann H, Trautwein C, et al. Long-term outcome of hepatitis C virus infection after liver transplantation. Hepatology. 25:1997;203-210.
10. Feray C, Gigou M, Samuel D, Paradis V, Mishiro S, Maertens G, et al. Influence of genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology. 108:1995;1088-1096.
11. Zhou S, Terrault N, Ferrell L, Hahn JA, Lau JY, Simmonds P, et al. Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia. Hepatology. 24:1996;1041-1046.
12. Gayowski T, Singh N, Marino I, Vargas H, Wagener M, Wannstedt C, et al. Hepatitis C virus genotypes in liver transplant recipients: impact on posttransplant recurrence, infections, response to interferon-alpha and outcome. Transplantation. 64:1997;422-426.
13. Gretch D, Bacchi C, Corey L, Dela Rosa C, Lesniewski RR, Kowdley K, et al. Persistent hepatitis C virus infection after liver transplantation: clinical and virological features. Hepatology. 22:1995;1-9.
14. Chazouilleres O, Kim M, Combs C, Ferrell L, Bacchetti P, Roberts J, et al. Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology. 106:1994;994-999.
15. Gane E, Naoumov N, Qian K, Mondelli MU, Maertens G, Portmann BC, et al. A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology. 110:1996;167-177.
16. DiMartino V, Saurini F, Samuel D, Gigou M, Dussaix E, Reynes M, et al. Long-term longitudinal study of intrahepatic hepatitis C virus replication after liver transplantation. Hepatology. 26:1997;1343-1350.
17. Casavilla A, Mateo R, Rakela J, Irish W, Starzl TE, Fung JJ. Impact of hepatitis C viral infection on survival following primary liver transplantation under FK506 (prograf). (abstract) AASLD Single Topic Symposium. Reston. VA. March 1995.
18. Sheiner PA, Schwartz ME, Mor E, Schluger LK, Theise N, Kishikawa K, et al. Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation. Hepatology. 21:1995;30-34.
19. Berenguer M, Prieto M, Córdoba J, Rayón M, Carrasco D, Olaso V, et al. Early development of chronic active hepatitis in recurrent hepatitis C virus infection after liver transplantation: association with treatment of rejection. J Hepatol. 28:1998;756-763.
20. Rosen HR, Martin P, Shackleton CR, Gralnek IM, Farmer DA, McDiarmid SV, et al. Use of OKT3 use is associated with early and severe recurrence of hepatitis C after liver transplantation. Am J Gastroenterol. 92:1997;1453-1457.
21. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet. 349:1997;825-832.
22. Pol S, Fontaine H, Carnot F, Zylberberg H, Berthelot P, Brechot C, et al. Predictive factors for development of cirrhosis in parenterally acquired chronic hepatitis C: a comparison between immunocompetent and immunocompromised patients. J Hepatol. 29:1998;12-19.
23. Charlton M, Seaberg E, Wiesner R, Everhart J, Zetterman R, Lake J, et al. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology. 28:1998;823-830.
24. Braun F, Lorf T, Ringe B. Update of current immunosuppressive drugs used in clinical organ transplantation. Transpl Int. 11:1998;77-81.
25. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1:1981;431-435.
26. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology. 19:1994;1513-1520.
27. SAS Institute, Inc. SAS/STAT Software: Changes and Enhancements through Release 6.12. 1997;571-701 SAS Institute Inc, Cary, NC.
28. Shapiro SS, Wilk MB. An analysis of variance test for normality. (complete samples) Biometrika. 52:1965;591-611.
29. SAS Institute, Inc. SAS Procedures Guide. 1990;493-502 SAS Institute Inc, Cary, NC.
30. SAS Institute, Inc. SAS/STAT User's Guide. 1994;997-1025 SAS Institute Inc, Cary, NC.
31. Fattovich G, Giustina G, Degos F, Tremolada F, Diodati G, Almasio P, et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology. 112:1997;463-472.
32. Belle SH, Beringer KC, Detre KM. Recent findings concerning liver transplantation in the United States. Terasaki PI, Cecka JM. Clinical Transplants 1996, 1st ed. 1997;15-30 UCLA Tissue Typing Laboratory, Los Angeles.